Learn Details of the Advances in Neuroendocrine Carcinoma Market Forecast and Segments, 2016-2026

Submitted by: Submitted by

Views: 10

Words: 567

Pages: 3

Category: Other Topics

Date Submitted: 03/21/2016 02:01 AM

Report This Essay

Neuroendocrine tumors (NETs) are malignant tumors that originate in endocrine cells and targets digestive tract that misbalances hormonal release. Neuroendocrine tumors are three types which include Pheochromocytoma, Merkel cell cancer, and neuroendocrine carcinoma. Neuroendocrine cells also present in the neuroendocrine system that includes pituitary gland, pineal gland, thyroid gland, parathyroid and adrenal glands. Physiological changes in the neuroendocrine cells may cause formation of two types of tumors–functional and nonfunctional tumors. Functional tumors develop another endocrine cells and nonfunctional tumors may cause physiological changes and based on the cause it treated. Neuroendocrine carcinoma are classified in two categories namely carcinoids and pancreatic endocrine tumors.

Carcinoid tumors, originating in the neuroendocrine system, usually appear in the digestive system i.e. in stomach and appendix. Besides, some carcinoid tumors develop in other organs such as lungs, thymus and ovaries. Due to their gradual growth, the symptoms of neuroendocrine carcinoma are not visible at early stages and are discovered only during undergoing an unrelated surgery. Tumors originating in the pancreas are named depending on the type of hormone released. For example, a tumor called gastrinoma is a tumor that release gastrin which results in excessive secretion of gastric acid.

Request free sample Report: http://www.futuremarketinsights.com/reports/sample/rep-gb-1278

Surgery is the first line therapy for removing affected neuroendocrine cells, thereafter, medication is used for treating neuroendocrine carcinoma. Sunitinib and Afinitor drugs are commonly used drugs for treatment of neuroendocrine carcinoma treatment.

Immune system suppression and exposure to arsenic are the major risk factors for neuroendocrine carcinoma.

Neuroendocrine Carcinoma Market: Drivers and Restraints

Significant increase in funding for treatment of cancer by various...